Financials
Income statement
Fiscal date | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
---|---|---|---|---|
Total reported revenue | 28.6B | 25.8B | 11.7B | 20.6B |
Cost of revenue | 24.3B | 21.7B | 11.0B | 18.9B |
Gross profit | 4.3B | 4.1B | 664M | 1.7B |
Operating expense | ||||
Research & development | 800M | 670M | 576M | 933M |
Selling general and admin | 1.5B | 1.5B | 1.0B | 1.4B |
Other operating expenses | — | — | — | — |
Operating income | 2.0B | 1.9B | -953M | -683M |
Non operating interest income | ||||
Income | 28M | 25M | 23M | 41M |
Expense | 181M | 272M | 190M | 199M |
Other income expense | -117M | 24M | -63M | -28M |
Pretax income | 1.8B | 1.6B | -1.2B | -869M |
Tax provision | 207M | 435M | -135M | 825M |
Net income | 1.6B | 1.2B | -1.0B | -1.7B |
Basic EPS | — | 0.8 | -0.7 | -1.1 |
Diluted EPS | — | 0.8 | -0.7 | -1.1 |
Basic average shares | — | 1.6B | 1.6B | 1.6B |
Diluted average shares | — | 1.6B | 1.6B | 1.6B |
EBITDA | 3.5B | 3.1B | 340M | 693M |
Net income from continuing op. | 1.6B | 1.2B | -1.0B | -1.7B |
Minority interests | 4M | -7M | 10M | -2M |
Preferred stock dividends | — | — | — | — |